ipso-Substitution and Unique Reactions of 1,3,6-Tri-tert-butylazulene
H), 7.22 (dd, J = 10.5, 2.0 Hz, 1 H, 5-H), 7.19 (d, J = 4.0 Hz, 1 H,
3-H), 1.59 (s, 9 H, tBu), 1.44 (s, 9 H, tBu) ppm.
13.6 Hz, 1 H, 6Ј-H), 7.66–7.51 (m, 4 H, 5,7,4Ј,5Ј-H), 6.65 (d, J =
6.8 Hz, 2 H, 2ЈЈ,6ЈЈ-H), 5.12 (dd, J = 6.8, 3.2 Hz, 2 H, 3ЈЈ,5ЈЈ-H),
4.85 (s, 1 H, 4ЈЈ-H), 1.58 (s, 9 H, tBu), 1.49 (s, 9 H, tBu) ppm. 13C
NMR (100 MHz, CDCl3): δ = 143.92, 142.85, 142.63, 142.35,
136.96, 132.97, 132.60, 126.64, 125.81, 124.98, 124.56, 121.86,
121.56, 119.12, 111.83, 111.55, 38.86, 33.25, 31.67, 31.42 ppm. IR
1,6-Di-tert-butyl-3-{1-[(trifluoromethyl)sulfonyl]-1,4-dihydropyridin-
4-yl}azulene (6): Tf2O (339 mg, 1.20 mmol) and pyridine (396 mg,
5.00 mmol) in CH2Cl2 (10 mL) were added at room temperature to
a solution of 1 (240 mg, 1.00 mmol) in CH2Cl2 (10 mL). The re-
sulting mixture was stirred at the same temperature for 30 min. The
solvent was removed under reduced pressure, and the residue was
purified by column chromatography on silica gel with CH2Cl2 to
give 6 (379 mg, 88 %) as blue crystals. M.p. 128.0–130.0 °C. 1H
NMR (400 MHz, CDCl3): δ = 8.60 (d, J = 10.8 Hz, 1 H, 4-H), 8.17
(d, J = 10.8 Hz, 1 H, 8-H), 7.62 (s, 1 H, 2-H), 8.02 (s, 1 H, 2-H),
7.24 (d, J = 10.8 Hz, 1 H, 7-H), 7.22 (d, J = 10.8 Hz, 1 H, 5-H),
6.55 (d, J = 8.4 Hz, 2 H, 2Ј,4Ј-H), 5.28 (dd, J = 8.4, 3.2 Hz, 2 H,
5Ј-H), 4.78 (s, 1 H, 4Ј-H), 1.57 (s, 9 H, tBu), 1.45 (s, 9 H, tBu)
ppm. 13C NMR (100 MHz, CDCl3): δ = 138.45, 135.34, 134.84,
(KBr disk): ν
= 1573 (m), 1494 (s), 1436 (m), 1413 (m), 1394
˜
max
(m), 1371 (m), 1223 (m), 1172 (s), 1116 (s), 1072 (m), 887 (m), 839
(s), 796 (m), 769 (m), 705 (m), 680 (m), 617 (m), 590 (m), 578 (m),
447 (m) cm–1. UV/Vis (CH2Cl2): λmax (log ε) = 238 (4.36), 288
(4.40), 360 (sh) (4.09), 378 (sh) (4.07), 548 (4.79) nm. UV/Vis (hex-
ane): λmax (log ε) = 236 (4.35), 258 (sh) (4.22), 286 (4.33), 302 (sh)
(4.18), 362 (4.18), 526 (4.84) nm. HRMS (ESI): calcd. for
C
30H32F6N2O4S2 + Na+ [M + Na]+ 685.1605; found 685.1600.
C30H32F6N2O4S2 (662.71): calcd. C 54.37, H 4.87, N 4.23; found
C 54.34, H 5.02, N 4.26.
134.53, 133.82, 131.34, 129.02, 128.21, 125.28, 119.88, 119.86, 6Ј-(1,6-Di-tert-butylazulen-3-yl)-3Ј-{1ЈЈ-[(trifluoromethyl)sulfonyl]-
119.82 (q, JC,F = 323.9 Hz), 119.07, 113.63, 38.32, 33.30, 32.13,
1ЈЈ,4ЈЈ-dihydropyridin-4ЈЈ-yl}-1Ј-[(trifluoromethyl)sulfonyl]-1Ј-aza-
hexa-1Ј,3Ј,5Ј-triene (8): Tf2O (282 mg, 1.00 mmol) and pyridine
31.78 ppm. IR (KBr disk): ν = 2965 (m), 2957 (m), 2907 (m),
˜
max
2872 (m), 1580 (m), 1410 (s), 1368 (m), 1285 (m), 1233 (s), 1196 (95 mg, 1.2 mmol) in CH2Cl2 (5 mL) were added at room tempera-
(s), 1159 (s), 1076 (m), 949 (s), 810 (m), 696 (s), 594 (s), 569 (m),
ture to a solution of 7 (227 mg, 0.503 mmol) in CH2Cl2 (5 mL).
525 (m) cm–1. UV/Vis (CH2Cl2): λmax (log ε) = 243 (4.20), 261 The resulting mixture was stirred at the same temperature for
(4.02), 293 (4.70), 303 (4.75), 345 (sh) (3.64), 355 (3.78), 367 (3.49),
372 (3.64), 458 (sh) (1.87), 598 (2.53), 648 (sh) (2.42) nm. HRMS
30 min. The solvent was removed under reduced pressure, and the
residue was purified by column chromatography on silica gel with
(ESI): calcd. for C24H28F3NO2S + Na+ [M + Na]+ 474.1690; found CH2Cl2 to give 8 (278 mg, 84%).
474.1685. C24H28F3NO2S (451.55): calcd. C 63.84, H 6.25, N 3.10;
found C 63.77, H 6.15, N 3.14.
1,6-Di-tert-butyl-3-(pyridin-4-yl)azulene (9)
Treatment of 6 with KOH in EtOH: KOH (561 mg, 10.0 mmol) was
6Ј-(1,6-Di-tert-butylazulen-3-yl)-1Ј-[(trifluoromethyl)sulfonyl]-1Ј-
azahexa-1Ј,3Ј,5Ј-triene (7) and 6Ј-(1,6-Di-tert-butylazulen-3-yl)-3Ј-
{1ЈЈ-[(trifluoromethyl)sulfonyl]-1ЈЈ,4ЈЈ-dihydropyridin-4ЈЈ-yl}-1Ј-[(tri-
fluoromethyl)sulfonyl]-1Ј-azahexa-1Ј,3Ј,5Ј-triene (8): Tf2O (339 mg,
1.20 mmol) and pyridine (119 mg, 1.50 mmol) in CH2Cl2 (10 mL)
were added at room temperature to a solution of 1 (240 mg,
1.00 mmol) in CH2Cl2 (10 mL). The resulting mixture was stirred at
the same temperature for 10 min. The solvent was removed under
reduced pressure, and the residue was purified by column
chromatography on silica gel with CH2Cl2 to give 7 (415 mg, 92%)
as metallic-green needles and 8 (33 mg, 5%) as metallic-green need-
les.
added at room temperature to a solution of 6 (451 mg, 1.00 mmol)
in EtOH (20 mL). The resulting mixture was heated at reflux for
30 min, poured into water, extracted with CH2Cl2, and dried with
MgSO4. The solvent was removed under reduced pressure, and the
residue was purified by column chromatography on silica gel with
AcOEt to give 9 (323 mg, 95%) as blue crystals.
Treatment of 6 with tBuOK in DMSO: tBuOK (336 mg, 3.00 mmol)
was added at room temperature to a solution of 6 (451 mg,
1.00 mmol) in DMSO (20 mL). The resulting mixture was stirred
at the same temperature for 10 min, poured into water, extracted
with toluene, and dried with MgSO4. The solvent was removed
under reduced pressure, and the residue was purified by column
chromatography on silica gel with AcOEt and by GPC with CHCl3
to give 9 (194 mg, 57%).
1
Compound 7: M.p. 210.0–218.0 °C (hexane). H NMR (500 MHz,
CDCl3): δ = 8.66 (d, J = 10.5 Hz, 1 H, 4-H), 8.63 (d, J = 10.5 Hz,
1 H, 2Ј-H), 8.46 (d, J = 10.5 Hz, 1 H, 8-H), 8.04 (s, 1 H, 2-H), 7.81
(d, J = 14.5 Hz, 1 H, 6Ј-H), 7.66 (t, J = 10.5 Hz, 1 H, 4Ј-H), 7.58
(d, J = 10.5, 2.0 Hz, 1 H, 5-H), 7.55 (d, J = 10.5, 2.0 Hz, 1 H, 7-
H), 7.13 (dd, J = 14.5, 10.5 Hz, 1 H, 5Ј-H), 6.57 (dd, J = 14.5,
1
Compound 9: M.p. 126.0–127.0 °C. H NMR (400 MHz, CDCl3):
δ = 8.68 (d, J = 10.8 Hz, 1 H, 8-H), 8.64 (d, J = 5.6 Hz, 2 H, 2Ј,6Ј-
H), 8.50 (d, J = 10.8 Hz, 1 H, 4-H), 7.89 (s, 1 H, 2-H), 7.52 (d, J
= 5.6 Hz, 2 H, 3Ј,5Ј-H), 7.35 (dd, J = 10.8, 2.0 Hz, 1 H, 7-H), 7.33
(dd, J = 10.8, 2.0 Hz, 1 H, 5-H), 1.62 (s, 9 H, tBu), 1.46 (s, 9 H,
tBu) ppm. 13C NMR (100 MHz, CDCl3): δ = 162.36, 149.68,
145.14, 138.92, 136.16, 135.75, 135.44, 134.60, 133.82, 124.95,
123.93, 122.08, 120.28, 38.31, 33.13, 31.99, 31.67 ppm. IR (KBr
10.5 Hz, 1 H, 3Ј-H), 1.59 (s, 9 H, tBu), 1.48 (s, 9 H, tBu) ppm. 13
C
NMR (100 MHz, CDCl3): δ = 177.90, 164.45, 143.62, 141.75,
141.51, 141.03, 136.67, 132.86, 132.18, 125.85, 124.97, 124.16,
122.79, 122.49, 121.13, 119.47 (q, JC,F = 310.2 Hz), 38.76, 33.27,
31.65, 31.50 ppm. IR (KBr disk): ν
= 2964 (m), 1570 (s), 1498
˜
max
disk): ν
= = 3067 (s), 3030 (s), 2963 (s), 2905 (s), 1593 (s), 1578
(s), 1439 (m), 1394 (m), 1338 (m), 1184 (s), 1157 (s), 1115 (s), 1070
(m), 1022 (m), 831 (s), 796 (m), 769 (m), 758 (m), 630 (m), 571 (m)
cm–1. UV/Vis (CH2Cl2): λmax (log ε) = 236 (4.35), 258 (sh) (4.22),
286 (4.32), 372 (4.13), 394 (sh) (3.64), 355 (3.78), 367 (3.49), 372
(3.64), 560 (4.85), 610 (sh) (4.71) nm. UV/Vis (hexane): λmax (log ε)
= 236 (4.35), 258 (sh) (4.22), 286 (4.33), 302 (sh) (4.18), 362 (4.18),
526 (4.84) nm. HRMS (ESI): calcd. for C24H28F3NO2S + Na+ [M
+ Na]+ 474.1690; found 474.1685. C24H28F3NO2S (451.55): calcd.
C 63.84, H 6.25, N 3.10; found C 64.11, H 6.44, N 3.09.
˜
max
(s), 1545 (m), 1518 (m), 1495 (m), 1460 (m), 1427 (m), 1390 (m),
1365 (m), 1240 (m), 1217 (m), 1199 (m), 835 (s), 825 (s), 692 (m),
617 (m), 557 (m), 416 (m) cm–1. UV/Vis (CH2Cl2): λmax (log ε) =
246 (4.30), 263 (4.10), 289 (4.40), 317 (4.49), 347 (3.79), 358 (sh)
(3.83), 389 (4.04), 473 (1.96), 594 (2.57), 641 (2.47), 715 (1.93) nm.
UV/Vis (AcOH): λmax (log ε) = 292 (4.48), 338 (sh) (4.24), 350
(4.31), 438 (4.40) nm. HRMS (ESI): calcd. for C23H27N + H+ [M
+ H]+ 318.2222; found 318.2216. C23H27N (317.47): calcd. C 87.02,
H 8.57, N 4.41; found C 86.86, H 8.46, N 4.40.
1
Compound 8: M.p. 171.0–176.0 °C (AcOEt). H NMR (400 MHz,
CDCl3): δ = 8.68 (d, J = 10.4 Hz, 1 H, 4-H), 8.49 (d, J = 10.4 Hz,
1 H, 8-H), 8.48 (s, 1 H, 2Ј-H), 7.96 (s, 1 H, 2-H), 7.76 (d, J =
Treatment of 2 with TPT: Tf2O (677 mg, 2.40 mmol) and pyridine
(791 mg, 10.0 mmol) in CH2Cl2 (10 mL) were added at room tem-
Eur. J. Org. Chem. 2009, 1554–1563
© 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
1561